Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
This study has been completed.
Sponsor:
Ludwig Institute for Cancer Research
Collaborator:
Memorial Sloan-Kettering Cancer Center
Information provided by:
Ludwig Institute for Cancer Research
ClinicalTrials.gov Identifier:
NCT00199888
First received: September 13, 2005
Last updated: August 29, 2006
Last verified: August 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | June 2006 |
| Estimated Primary Completion Date: | No date given |